Prostate Cancer Reports
54

Volume 6 Number 5
May 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 5, May



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT





DIAGNOSIS

.

Barry MJ.
Screening for Prostate Cancer: Is the Third Trial the Charm?
JAMA. 2018 Mar 6;319(9):868-869. doi: 10.1001/jama.2018.0153. Erratum in: JAMA. 2018 Apr 10;319(14 ):1510
Comment on: Martin RM et al., Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. (JAMA. 2018 Mar 6)
Source | Abstract | Full text | Similar articles | Erratum



.

Kelsey R.
Prostate cancer: Solo PSA test does not lower mortality.
Nat Rev Urol. 2018 Mar 27. doi: 10.1038/nrurol.2018.41. [Epub ahead of print]
Comment on: Martin RM et al., Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. (JAMA. 2018 Mar 6)
Source | Abstract | Full text | Similar articles



.

Martin RM, Donovan JL, Turner EL, Metcalfe C, Young GJ, Walsh EI, Lane JA, Noble S, Oliver SE, Evans S, Sterne JAC, Holding P, Ben-Shlomo Y, Brindle P, Williams NJ, Hill EM, Ng SY, Toole J, Tazewell MK, Hughes LJ, Davies CF, Thorn JC, Down E, Davey Smith G, Neal DE, Hamdy FC; CAP Trial Group.
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
JAMA. 2018 Mar 6;319(9):883-895. doi: 10.1001/jama.2018.0154.
Source | Abstract | Full text | Similar articles



.

Panebianco V, Barchetti G, Simone G, Del Monte M, Ciardi A, Grompone MD, Campa R, Indino EL, Barchetti F, Sciarra A, Leonardo C, Gallucci M, Catalano C.
Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
Eur Urol. 2018 Mar 19. pii: S0302-2838(18)30183-0. doi: 10.1016/j.eururo.2018.03.007. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Wei J, Zhu H, Liao X.
Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment.
Oncotarget. 2018 Jan 24;9(18):14630-14641. doi: 10.18632/oncotarget.24318. eCollection 2018 Mar 6.
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION

.

Capogrosso P, Ventimiglia E, Boeri L, Cazzaniga W, Chierigo F, Montorsi F, Salonia A.
Male infertility as a proxy of the overall male health status.
Minerva Urol Nefrol. 2018 Mar 28. doi: 10.23736/S0393-2249.18.03063-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Huang TB, Zhou GC, Dong CP, Wang LP, Luan Y, Ye JT, Gu X, Yao XD, Zheng JH, Ding XF.
Marital status independently predicts prostate cancer survival in men who underwent radical prostatectomy: An analysis of 95,846 individuals.
Oncol Lett. 2018 Apr;15(4):4737-4744. doi: 10.3892/ol.2018.7964. Epub 2018 Feb 6.
Source | Abstract | Full text | Similar articles



.

Ugge H, Udumyan R, Carlsson J, Davidsson S, Andrén O, Montgomery S, Fall K.
Appendicitis before age 20 years is associated with an increased risk of later prostate cancer.
Cancer Epidemiol Biomarkers Prev. 2018 Mar 27. pii: cebp.1204.2017. doi: 10.1158/1055-9965.EPI-17-1204. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY

.

Inamura K.
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.
Oncotarget. 2018 Feb 16;9(18):14723-14737. doi: 10.18632/oncotarget.24515. eCollection 2018 Mar 6.
Source | Abstract | Full text | Similar articles



.

Singh G, Sankanagoudar S, Dogra P, Chandra NC.
Interlink between cholesterol and cell cycle in prostate carcinoma.
Indian J Med Res. 2017 Nov;146(Suppl):S38-S44. doi: 10.4103/ijmr.IJMR_1639_15.
Source | Abstract | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Bertolo R, Tracey A, Dasgupta P, Rocco B, Micali S, Bianchi G, Hampton L, Tewari AK, Porpiglia F, Autorino R.
Supra-pubic versus urethral catheter after robot-assisted radical prostatectomy: systematic review of current evidence.
World J Urol. 2018 Mar 29. doi: 10.1007/s00345-018-2275-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Tilki D, Preisser F, Karakiewicz P, Shariat SF, Graefen M, Huland H, Chun FK, Pompe RS.
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy.
World J Urol. 2018 Mar 26. doi: 10.1007/s00345-018-2274-y. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Chen YA, Lin YJ, Lin CL, Lin HJ, Wu HS, Hsu HY, Sun YC, Wu HY, Lai CH, Kao CH.
Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia.
Front Pharmacol. 2018 Mar 22;9:225. doi: 10.3389/fphar.2018.00225. eCollection 2018.
Source | Abstract | Full text | Similar articles



.

Fowke JH, Motley SS.
Statin Use Linked with a Decrease in the Conversion from High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) to Prostate Cancer.
Carcinogenesis. 2018 Apr 3. doi: 10.1093/carcin/bgy050. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Mascan B, Marignol L.
Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe?
Anticancer Res. 2018 Apr;38(4):1897-1902.
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT

.

Lawton CAF.
Prostate Cancer: Improving the Flow of Research.
Radiology. 2018 Apr;287(1):5-9. doi: 10.1148/radiol.2018171046.
Source | Abstract | Full text | Similar articles



PROGNOSIS

.

Aly M, Hashim M, Heeg B, Liwing J, Leval A, Mehra M, Lawson J, Brookman-May SD, Akre O.
Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer-A Systematic Literature Review and Pooling of Individual Participant Data.
Eur Urol Focus. 2018 Apr 4. pii: S2405-4569(18)30088-9. doi: 10.1016/j.euf.2018.03.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Moretti KL, Shi Z, Kopsaftis T, O'Callaghan ME.
Delays in radical prostatectomy for prostate cancer and survival outcomes.
World J Urol. 2018 Mar 16. doi: 10.1007/s00345-018-2265-z. [Epub ahead of print]
Comment on: Morini MA et al.,Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? (World J Urol. 2018 Mar 16)
Source | Abstract | Full text | Similar articles



.

Morini MA, Muller RL, de Castro Junior PCB, de Souza RJ, Faria EF.
Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter?
World J Urol. 2018 Mar 16. doi: 10.1007/s00345-018-2251-5. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Nagao K, Matsuyama H, Matsumoto H, Nasu T, Yamamoto M, Kamiryo Y, Baba Y, Suga A, Tei Y, Yoshihiro S, Aoki A, Shimabukuro T, Joko K, Sakano S, Takai K, Yamaguchi S, Akao J, Kitahara S; Yamaguchi Uro-Oncology Group.
Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
Int J Clin Oncol. 2018 Mar 27. doi: 10.1007/s10147-018-1272-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Pereira-Azevedo N, Verbeek JFM, Nieboer D, Bangma CH, Roobol MJ.
Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.
Transl Androl Urol. 2018 Feb;7(1):18-26. doi: 10.21037/tau.2017.12.21.
Source | Abstract | Full text | Similar articles



.

Pompe RS, Gild P, Karakiewicz PI, Bock LP, Schlomm T, Steuber T, Graefen M, Huland H, Tian Z, Tilki D.
Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
Prostate. 2018 Mar 23. doi: 10.1002/pros.23511. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



TREATMENT

.

Giannarini G, Fossati N, Gandaglia G, Cucchiara V, Ficarra V, Mirone V, Montorsi F, Briganti A.
Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?
Eur Urol. 2018 Apr 3. pii: S0302-2838(18)30202-1. doi: 10.1016/j.eururo.2018.03.021. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Hawkes N.
Sixty seconds on . . . prostate cancer.
BMJ. 2018 Mar 27;360:k1385. doi: 10.1136/bmj.k1385.
Comment on: Wilt TJ et al., Follow-up of Prostatectomy versus Observation for Early Prostate Cancer. (N Engl J Med. 2017 Jul 13)
Source | Abstract | Full text | Similar articles



.

Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.
Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.
Cancer Med. 2018 Mar 23. doi: 10.1002/cam4.1408. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Maurer T, Robu S, Schottelius M, Schwamborn K, Rauscher I, van den Berg NS, van Leeuwen FWB, Haller B, Horn T, Heck MM, Gschwend JE, Schwaiger M, Wester HJ, Eiber M.
99mTechnetium-based Prostate-specific Membrane Antigen-radioguided Surgery in Recurrent Prostate Cancer.
Eur Urol. 2018 Apr 3. pii: S0302-2838(18)30189-1. doi: 10.1016/j.eururo.2018.03.013. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Poorthuis MHF, Vernooij RWM, van Moorselaar RJA, de Reijke TM.
Second-line therapy in patients with metastatic castration-resistant prostate cancer with progression after or under docetaxel: A systematic review of nine randomized controlled trials.
Semin Oncol. 2017 Oct;44(5):358-371. doi: 10.1053/j.seminoncol.2017.10.005. Epub 2017 Oct 10.
Source | Abstract | Full text | Similar articles



.

Sæterdal I, Desser A, Pike E, Hamidi V, Harboe I, Odgaard-Jensen J, Klemp M.
Health Technology Assessment of Four Drugs for Patients with Metastatic Castration Resistant Prostate Cancer [Internet].
Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2016 Aug.
Source | Abstract | Full text | Similar articles



.

Sebesta EM, Anderson CB.
The Surgical Management of Prostate Cancer.
Semin Oncol. 2017 Oct;44(5):347-357. doi: 10.1053/j.seminoncol.2018.01.003. Epub 2018 Feb 13.
Source | Abstract | Full text | Similar articles



.

Taneja SS.
Re: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
J Urol. 2017 May;197(5):1265-1266. doi: 10.1016/j.juro.2017.02.004. Epub 2017 Feb 9.
Source | Abstract | Full text | Similar articles